<DOC>
	<DOCNO>NCT00810121</DOCNO>
	<brief_summary>Primary objective : To demonstrate non-inferiority Bi-Profenid 100 mg x 2 day versus Bi-Profenid 150 mg x 2 day patient present pain relate close , benign , acute post-traumatic condition motor system acute , non-infectious rheumatologic condition , compare , one hand , change rest pain intensity entire day , measured end day use numeric scale ( NS ) , 5 day , hand , total intake 5 day concomitant analgesic . Secondary Objectives : - To describe concomitant analgesic treatment - To describe time baseline use step I , II III analgesic - To evaluate patient pain relief use Likert 4-class scale ( complete substantial relief , moderate relief slight relief absence relief ) D5 - To evaluate change intensity pain move , entire day , measured end day use numeric scale , 5 day - To evaluate patient overall satisfaction end treatment use 4-point Simple Verbal Scale ( SVS ) ( satisfied , somewhat satisfied , somewhat unsatisfied , unsatisfied ) - To evaluate patient overall satisfaction end study use 4-point Simple Verbal Scale ( EVS ) ( satisfied , somewhat satisfied , somewhat unsatisfied , unsatisfied ) - To compare safety two treatment</brief_summary>
	<brief_title>Study Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting Post-traumatic Rheumatologic Acute Affections Locomotor Apparatus ( BIPROPAIN )</brief_title>
	<detailed_description />
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Inclusion criterion : Male female , 18 less 65 year age , Women use method contraception negative pregnancy test enter study , woman menopausal least 1 year , Patients meet one follow criterion : Closed benign trauma motor system occur within last 24 hour , Contusion motor system occur within last 24 hour , Acute rheumatologic condition ( acute low back pain , lumbar sciatica , cervicobrachial neuralgia ) , Abarticular rheumatism , Requiring treatment BiProfenid 5 day , With rest pain intensity measure numeric scale baseline &gt; or= 3 ( administration treatment ) , Receiving prior medical examination suit study Exclusion criterion : Need surgery , Need hospitalization , Need analgesic step I baseline visit , Need treatment another selective nonselective NSAID ( per o and/or topical ) , include aspirin , selective cyclooxygenase 2 inhibitor , corticosteroid muscle relaxant baseline throughout study , Serious trauma : knee luxation , fracture , rupture Achilles tendon rupture , Sprain treat cast , Bursitis , Local and/or general severe infection , Pregnant nursing woman , Hypersensitivity ketoprofen excipients product , Previous history asthma trigger take ketoprofen substance similar activity NSAIDs aspirin , Gastrointestinal haemorrhage , cerebrovascular haemorrhage active haemorrhage , Previous history digestive haemorrhage perforation previous NSAID treatment , Active intestinal ulcer , Active peptic ulcer , previous history peptic ulcer recurrent haemorrhage ( 2 separate episode haemorrhage ulceration detect ) , Severe hepatic failure , Severe renal failure , Severe heart failure , Uncontrolled hypertension , Hypersensitivity intolerance gluten , due presence wheat starch ( gluten ) , Patients treat oral anticoagulant , heparin , platelet antiaggregants , selective serotonin reuptake inhibitor ( SSRI ) , lithium , methotrexate , pemetrexed immunosuppressants The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>